In another study, patients with R/R B-cell acute lymphoblastic leukemia (B-ALL) received CNCT19 cells, a new CD19 CAR-T cell produce that targets a different binding epitope on CD19 than FMC63 CAR-T cells. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.